243 related articles for article (PubMed ID: 24116912)
1. Telodendrimer-based nanocarriers for the treatment of ovarian cancer.
Xiao K; Suby N; Li Y; Lam KS
Ther Deliv; 2013 Oct; 4(10):1279-92. PubMed ID: 24116912
[TBL] [Abstract][Full Text] [Related]
2. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
3. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.
Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS
Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491
[TBL] [Abstract][Full Text] [Related]
4. Multiscale approach to investigate self-assembly of telodendrimer based nanocarriers for anticancer drug delivery.
Jiang W; Luo J; Nangia S
Langmuir; 2015 Apr; 31(14):4270-80. PubMed ID: 25532019
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. A drug-specific nanocarrier design for efficient anticancer therapy.
Shi C; Guo D; Xiao K; Wang X; Wang L; Luo J
Nat Commun; 2015 Jul; 6():7449. PubMed ID: 26158623
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
Mohamed S; Parayath NN; Taurin S; Greish K
Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
[TBL] [Abstract][Full Text] [Related]
8. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
[TBL] [Abstract][Full Text] [Related]
9. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
Elbayoumi TA
Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
[No Abstract] [Full Text] [Related]
10. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
11. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
Bugno J; Hsu HJ; Hong S
J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer.
Xiao W; Luo J; Jain T; Riggs JW; Tseng HP; Henderson PT; Cherry SR; Rowland D; Lam KS
Int J Nanomedicine; 2012; 7():1587-97. PubMed ID: 22605931
[TBL] [Abstract][Full Text] [Related]
13. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
[TBL] [Abstract][Full Text] [Related]
14. Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
Cai L; Xu G; Shi C; Guo D; Wang X; Luo J
Biomaterials; 2015 Jan; 37():456-468. PubMed ID: 25453973
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
Lee MS; Dees EC; Wang AZ
Oncology (Williston Park); 2017 Mar; 31(3):198-208. PubMed ID: 28299757
[TBL] [Abstract][Full Text] [Related]
16. Size matters: gold nanoparticles in targeted cancer drug delivery.
Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
18. Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.
Huang W; Wang X; Shi C; Guo D; Xu G; Wang L; Bodman A; Luo J
Mol Pharm; 2015 Apr; 12(4):1216-29. PubMed ID: 25692376
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.
Wang L; Shi C; Wright FA; Guo D; Wang X; Wang D; Wojcikiewicz RJH; Luo J
Cancer Res; 2017 Jun; 77(12):3293-3305. PubMed ID: 28396359
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
